Back to Articles
GeneralBusiness Today

Amneal expands India operations after Kashiv buy, builds biosimilars portfolio

The US drugmaker is building on Kashiv BioSciences' biologics capabilities to expand its India play across biosimilars, complex medicines, manufacturing and R&D.

Attribution

This digest is published with acknowledgment to Business Today. For the complete analysis, headnotes, and citations, please refer to the source.

Read on Business Today

More Articles